Search research articles
Contact Us
Filters
Showing results (31-40 of 365) with videos related to
Page
of 37
Sort By:
JAMA
|
September 21, 2006
Changing incidence of thyroid cancer
Yawei Zhang, Yong Zhu, Harvey A Risch
Der Anaesthesist
|
March 1, 1997
[The "TAS-Analyzer"]
F Mertzlufft, A Risch, U T Seyfert
The New England Journal of Medicine
|
January 5, 2002
Ovarian cancer, oral contraceptives, and BRCA mutations
S A Narod, P Sun, H A Risch, et al.
Recent Results in Cancer Research. Fortschritte Der Krebsforschung. Progres Dans Les Recherches Sur Le Cancer
|
February 23, 1999
Impact of adduct determination on the assessment of cancer susceptibility
H Bartsch, M Rojas, K Alexandrov, et al.
Gynecologic Oncology
|
November 26, 2010
Pre- and post-diagnosis body mass index, weight change, and ovarian cancer mortality
Yang Zhou, Melinda L Irwin, Harvey A Risch
Trends in Genetics : TIG
|
December 1, 1995
Xenogenetics in multifactorial disease susceptibility
E Sim, L A Stanley, A Risch, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
December 20, 2013
Response to Weidhaas and Slack re: Comments on "The role of <i>KRAS</i> rs61764370 in invasive epithelial ovarian cancer: implication for clinical testing"
Harvey A Risch, Andrew Berchuck, Paul D P Pharoah
The Journal of Rheumatology
|
August 18, 1999
Acetylation status is associated with serological changes but not clinically significant disease in patients receiving procainamide
A B Mongey, E Sim, A Risch, et al.
Human Molecular Genetics
|
February 1, 1995
Slow N-acetylation genotype is a susceptibility factor in occupational and smoking related bladder cancer
A Risch, D M Wallace, S Bathers, et al.
Pharmacogenetics
|
October 1, 1992
Genotyping human polymorphic arylamine N-acetyltransferase: identification of new slow allotypic variants
D Hickman, A Risch, J P Camilleri, et al.
Page
of 37
Search research articles
Search
Showing results (31-40 of 365) with videos related to
Sort By:
Page
of 37
JAMA
|
September 21, 2006
Changing incidence of thyroid cancer
Yawei Zhang, Yong Zhu, Harvey A Risch
Der Anaesthesist
|
March 1, 1997
[The "TAS-Analyzer"]
F Mertzlufft, A Risch, U T Seyfert
The New England Journal of Medicine
|
January 5, 2002
Ovarian cancer, oral contraceptives, and BRCA mutations
S A Narod, P Sun, H A Risch, et al.
Recent Results in Cancer Research. Fortschritte Der Krebsforschung. Progres Dans Les Recherches Sur Le Cancer
|
February 23, 1999
Impact of adduct determination on the assessment of cancer susceptibility
H Bartsch, M Rojas, K Alexandrov, et al.
Gynecologic Oncology
|
November 26, 2010
Pre- and post-diagnosis body mass index, weight change, and ovarian cancer mortality
Yang Zhou, Melinda L Irwin, Harvey A Risch
Trends in Genetics : TIG
|
December 1, 1995
Xenogenetics in multifactorial disease susceptibility
E Sim, L A Stanley, A Risch, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
December 20, 2013
Response to Weidhaas and Slack re: Comments on "The role of <i>KRAS</i> rs61764370 in invasive epithelial ovarian cancer: implication for clinical testing"
Harvey A Risch, Andrew Berchuck, Paul D P Pharoah
The Journal of Rheumatology
|
August 18, 1999
Acetylation status is associated with serological changes but not clinically significant disease in patients receiving procainamide
A B Mongey, E Sim, A Risch, et al.
Human Molecular Genetics
|
February 1, 1995
Slow N-acetylation genotype is a susceptibility factor in occupational and smoking related bladder cancer
A Risch, D M Wallace, S Bathers, et al.
Pharmacogenetics
|
October 1, 1992
Genotyping human polymorphic arylamine N-acetyltransferase: identification of new slow allotypic variants
D Hickman, A Risch, J P Camilleri, et al.
Page
of 37